264 related articles for article (PubMed ID: 25753832)
1. Increased levels of plasma glial-derived neurotrophic factor in children with attention deficit hyperactivity disorder.
Shim SH; Hwangbo Y; Yoon HJ; Kwon YJ; Lee HY; Hwang JA; Kim YK
Nord J Psychiatry; 2015; 69(7):546-51. PubMed ID: 25753832
[TBL] [Abstract][Full Text] [Related]
2. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
Bilgiç A; Toker A; Işık Ü; Kılınç İ
Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
[TBL] [Abstract][Full Text] [Related]
3. Altered serum levels of vascular endothelial growth factor and glial-derived neurotrophic factor but not fibroblast growth factor-2 in treatment-naive children with attention deficit/hyperactivity disorder.
Yurteri N; Şahin İE; Tufan AE
Nord J Psychiatry; 2019; 73(4-5):302-307. PubMed ID: 31170860
[No Abstract] [Full Text] [Related]
4. Association between serum levels of glial cell line-derived neurotrophic factor and inattention in adult patients with attention deficits/hyperactivity disorder.
Niitsu T; Oda Y; Idemoto K; Ota K; Liu J; Sasaki T; Nakazato M; Hashimoto K; Iyo M
Psychiatry Res; 2021 Feb; 296():113674. PubMed ID: 33385784
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD).
Shim SH; Hwangbo Y; Kwon YJ; Jeong HY; Lee BH; Lee HJ; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1824-8. PubMed ID: 18760321
[TBL] [Abstract][Full Text] [Related]
6. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder.
Shen Z; Zhu J; Yuan Y; Ren L; Qian M; Lin M; Cai M; Zhang Z; Shen X
Psychiatry Res; 2019 Jan; 271():319-324. PubMed ID: 30529313
[TBL] [Abstract][Full Text] [Related]
7. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
[TBL] [Abstract][Full Text] [Related]
8. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
[TBL] [Abstract][Full Text] [Related]
9. Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD).
Amiri A; Torabi Parizi G; Kousha M; Saadat F; Modabbernia MJ; Najafi K; Atrkar Roushan Z
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():20-4. PubMed ID: 23933054
[TBL] [Abstract][Full Text] [Related]
10. Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD).
Scassellati C; Zanardini R; Tiberti A; Pezzani M; Valenti V; Effedri P; Filippini E; Conte S; Ottolini A; Gennarelli M; Bocchio-Chiavetto L
Eur Child Adolesc Psychiatry; 2014 Mar; 23(3):173-7. PubMed ID: 23812866
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
[TBL] [Abstract][Full Text] [Related]
12. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
[TBL] [Abstract][Full Text] [Related]
13. Decreased plasma glial cell line-derived neurotrophic factor level in major depressive disorder is associated with age and clinical severity.
Sun J; Kong L; Wu F; Wei Y; Zhu Y; Yin Z; Deng X; Jiang X; Tang Y; Wang F
J Affect Disord; 2019 Feb; 245():602-607. PubMed ID: 30445385
[TBL] [Abstract][Full Text] [Related]
14. Serum nerve growth factor beta, brain- and glial-derived neurotrophic factor levels and psychopathology in unmedicated patients with schizophrenia.
Chu CS; Chu CL; Wu CC; Lu T
J Chin Med Assoc; 2018 Jun; 81(6):577-581. PubMed ID: 29366645
[TBL] [Abstract][Full Text] [Related]
15. Increased Serum Brain-derived Neurotrophic Factor, Nerve Growth Factor, Glial-derived Neurotrophic Factor and Galanin Levels in Children with Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment.
Gumus C; Yazici IP; Yazici KU; Ustundag B
Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):635-648. PubMed ID: 36263639
[TBL] [Abstract][Full Text] [Related]
16. Increased serum neurotrophin levels related to alcohol use disorder in a young population sample.
Lhullier AC; Moreira FP; da Silva RA; Marques MB; Bittencourt G; Pinheiro RT; Souza LD; Portela LV; Lara DR; Jansen K; Wiener CD; Oses JP
Alcohol Clin Exp Res; 2015 Jan; 39(1):30-3. PubMed ID: 25623403
[TBL] [Abstract][Full Text] [Related]
17. Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers.
Vogel SWN; Bijlenga D; Verduijn J; Bron TI; Beekman ATF; Kooij JJS; Penninx BWJH
Psychoneuroendocrinology; 2017 May; 79():31-39. PubMed ID: 28249186
[TBL] [Abstract][Full Text] [Related]
18. Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder.
Sahin S; Yuce M; Alacam H; Karabekiroglu K; Say GN; Salıs O
Int J Psychiatry Clin Pract; 2014 Oct; 18(4):280-7. PubMed ID: 24994482
[TBL] [Abstract][Full Text] [Related]
19. Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity.
Bergman O; Westberg L; Lichtenstein P; Eriksson E; Larsson H
Int J Neuropsychopharmacol; 2011 Nov; 14(10):1367-76. PubMed ID: 21466746
[TBL] [Abstract][Full Text] [Related]
20. Impact of Auditory Integration Therapy (AIT) on the Plasma Levels of Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Autism Spectrum Disorder.
Al-Ayadhi L; El-Ansary A; Bjørklund G; Chirumbolo S; Mostafa GA
J Mol Neurosci; 2019 Aug; 68(4):688-695. PubMed ID: 31073917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
